Prosecution Insights
Last updated: October 04, 2026
Application No. 18/042,943

COMPOSITION AND METHOD

Non-Final OA §103§112
Filed
Feb 24, 2023
Priority
Aug 25, 2020 — GB 2013271.8 +1 more
Examiner
LE, EMILY M
Art Unit
1793
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Metalchemy Limited
OA Round
3 (Non-Final)
18%
Grant Probability
At Risk
3-4
OA Rounds
10m
Est. Remaining
15%
With Interview

Examiner Intelligence

Grants only 18% of cases
18%
Career Allowance Rate
30 granted / 170 resolved
-47.4% vs TC avg
Minimal -3% lift
Without
With
+-3.1%
Interview Lift
resolved cases with interview
Typical timeline
4y 6m
Avg Prosecution
25 currently pending
Career history
209
Total Applications
across all art units

Statute-Specific Performance

§101
1.4%
-38.6% vs TC avg
§103
56.0%
+16.0% vs TC avg
§102
8.2%
-31.8% vs TC avg
§112
24.6%
-15.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 170 resolved cases

Office Action

§103 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 03/27/2026 has been entered. Status of Claims Claims 12-15 are cancelled. Claims 1-11 are pending and under examination. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-11 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 recites “kale (Brassica oleracea var Acephala group). Said recitation renders the claim indefinite. Said recitation recites “kale”, which is a species of “Brassica oleracea var Acephala group”. Said recitation also recites “Brassica oleracea var Acephala group” which includes non-heading cultivars that includes kale, collards, ornamental cabbage, ornamental kale, flowering kale and tree cabbage. Given this, it is not clear if the recitation is intended to be limiting to kale or all nonheading cultivars within the Brassica oleracea var Acephala group. Claim 1 is also indefinite for the being in improper Markush form for missing a conjunction between Markush group members (d) and (e). Claims 2-11 are also rejected for being dependent on a rejected claim. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(d): (d) REFERENCE IN DEPENDENT FORMS.—Subject to subsection (e), a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. The following is a quotation of pre-AIA 35 U.S.C. 112, fourth paragraph: Subject to the following paragraph [i.e., the fifth paragraph of pre-AIA 35 U.S.C. 112], a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. Claim 7 is rejected under 35 U.S.C. 112(d) or pre-AIA 35 U.S.C. 112, 4th paragraph, as being of improper dependent form for failing to further limit the subject matter of the claim upon which it depends, or for failing to include all the limitations of the claim upon which it depends. Claim 7 recites “at least one other plant selected form the group consisting of: (i) artichoke (Cynara cardunculus var scolymus); (ii) red cabbage (Brassica oleracea var. Capitata group var. rubra); (iii) rosemary (Salvia Rosmarinus); and (iv) watercress (Nasturtium officinale).” Said recitation already exist in the parent claim, claim 1. Hence, claim 7 does not further limit the claim upon which it depends on. Applicant may cancel the claim(s), amend the claim(s) to place the claim(s) in proper dependent form, rewrite the claim(s) in independent form, or present a sufficient showing that the dependent claim(s) complies with the statutory requirements. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. It is noted that Applicant’s specification contains assertion of unexpected and/or synergistic results. A careful of the specification and the data provided shows that unexpected and/or synergistic results has been established. Tables 3-4 of the specification demonstrate variation in data; however, because the samples are not of at least the same concentration, it is found that the assertion of unexpected results cannot be verified. Given this, the following is the obviousness rejection against the cited claims. Claim(s) 1-5, 7, and 9-10 is/are rejected under 35 U.S.C. 103 as being unpatentable Hoag (WO 2009140694), in view of: Korus (Korus. Effect of preliminary processing and method of preservation on the content of selected antioxidative compounds in kale (Brassica oleracea L. var. acephala) leaves. Food Chemistry. Vol. 129, Issue 1, pages 149-154, 2011.), and Sankar (Sankar. Origanum vulgare mediated biosynthesis of silver nanoparticles for its antibacterial and anticancer activity. Colloids and Surfaces B: Biointerfaces, 108 (2013) 80-84.) Regarding claims 1 and 7: Hoag teaches a method of producing metal nanoparticles. [Abstract] The method of Hoag includes dissolving metal ions and contacting the dissolved metal ion with a composition comprising plant extracts to produce metal nanoparticles. [0006] Hoag teaches the metal nanoparticles have a diameter between about 50 nm and about 500 nm. [0006] The diameter of Hoag is within the claimed range of 1 nm and 1 um. Hoag does not teach a composition comprising plant extracts from kale and oregano, and at least one of artichoke, red cabbage, rosemary, sage and watercress. However, Hoag teaches that “plant extract containing high concentration of reducing agents, including polyphenolic compounds can be used” to produce nanoparticles in addition to those form tea and coffee. And, Regarding kale, Korus teaches that kale leaves contain high concentration of polyphenols. [Abstract] Given this, it would have been obvious for one of ordinary skill in the art before the effective filing date to include kale extract in the composition comprising plant extract of Hoag. One of ordinary skill in the art would have been motivated to do so to produce metal nanoparticles. One of ordinary skill in the art would have had a reasonable expectation of success for doing so because Korus establishes that kale contains high concentration of polyphenols and Hoag establishes that plants with high concentration of polyphenols can be used to produce metal nanoparticles. Regarding oregano, Sankar teaches that oregano extract may be used to produce metal nanoparticles. [Title] Given this; it would have been obvious for one of ordinary skill in the art before the effective filing date to include oregano extract in the composition comprising plant extract of Hoag. One of ordinary skill in the art would have been motivated to do so to produce metal nanoparticles. One of ordinary skill in the art would have had a reasonable expectation of success for doing so because the art recognizes that oregano can be used to make metal nanoparticles. Regarding rosemary, Hoag listed extract from rosemary. [0073] In the instant case, it would have been obvious for one of ordinary skill in the art to include rosemary extract in the composition of plant extract of Hoag. One of ordinary skill in the art would have been motivated to do so to make metal nanoparticles. One of ordinary skill would have had a reasonable expectation of success for doing so because Hoag recognized rosemary as a reducing agent for producing metal nanoparticles. In all, Hoag, Korus and Sankar demonstrate that kale, oregano, and rosemary may be used in the production of metal nanoparticles. And, MPEP 2114.06 states, it is prima facie obvious to combine two compositions each of which is taught by the prior art to be useful for the same purpose, in order to form a third composition to be used for the very same purpose.... [T]he idea of combining them flows logically from there having been individually taught in the prior art." In re Kerkhoven, 626 F.2d 846, 850, 205 USPQ 1069, 1072 (CCPA 1980). Given this, the invention encompassed by claim 1 is rendered obvious. Regarding claim 2: Hoag teaches gold, silver, copper, platinum, iron, manganese and palladium at [0072-0073]; Chromium at [0075], Zinc at [0087], and Nickel at [0142]. Regarding claim 3: Hoag teaches silver as the metal. [0072-0073] Regarding claim 4: Hoag teaches gold as the metal. [0072-0073] Regarding claim 5: in the method of Hoag, the dissolved metal ion is present in the form of a solution of a metal salt. [0008] Regarding claim 9: Hoag, Korus nor Sankar teaches the claimed % by mass. However Hoag teaches the metal nanoparticles are produced using green synthesis approach. Hoag teaches that metal nanoparticles are synthesized by reducing the corresponding metal ion salt solutions. Green chemistry can be employed, for example, in the (i) choice of solvent, (ii) the choice of reducing agent, and (iii) the choice of capping agent (or dispersing agent) used. [0072] Additionally, Hoag notes that the composition comprising plant extract is concentrated as the concentration process can produce higher concentration of plant polyphenols, enabling a high concentration of dissolved metal to be used to make higher concentrations of metal nanoparticles. [0085] In the instant case, Hoag establishes that (i)-(iii) as result effective variables. Given this, it would have been obvious for one of ordinary skill in the art to have varied the % by mass of the extract. One of ordinary skill in the art would have been motivated to do so to produce of metal nanoparticles. One of ordinary y skill in the art would have had a reasonable expectation of success for doing so because varying of result effective variable is routinely practiced in the art. Regarding claim 10: As noted above, Hoag teaches a method of producing metal nanoparticles. [Abstract] The method of Hoag includes dissolving metal ions and contacting the dissolved metal ion with a composition comprising plant extracts to produce metal nanoparticles. [0006] Hoag does not teach that the solution of metal ions is added to the composition comprising plant extract. In the instant case, given that the process includes contacting the dissolved metal ion with a composition comprising plant extracts to produce metal nanoparticles, it logical follows that contact can be made in a finite number of ways. One way includes adding the solution of metal ions to the composition comprising plant extract. The other way includes adding the composition comprising plant extract to the solution of metal ions. Given that finite choices exist, it would have been obvious for one of ordinary skill to have added the solution of metal ions to the composition comprising plant extract. One of ordinary skill in the art would have been motivated to do so to produce metal nanoparticles. One of ordinary skill in the art would have had a reasonable expectation of success for doing so because given adding the solution of metal ions to the composition comprising plant extract would result contacting the dissolved metal ion with a composition comprising plant extracts to produce metal nanoparticles. Claim(s) 6 is/are rejected under 35 U.S.C. 103 as being unpatentable Hoag (WO 2009140694), in view of: Korus (Korus. Effect of preliminary processing and method of preservation on the content of selected antioxidative compounds in kale (Brassica oleracea L. var. acephala) leaves. Food Chemistry. Vol. 129, Issue 1, pages 149-154, 2011.), Sankar (Sankar. Origanum vulgare mediated biosynthesis of silver nanoparticles for its antibacterial and anticancer activity. Colloids and Surfaces B: Biointerfaces, 108 (2013) 80-84.), and Pethakamsetty (Pethakamsetty, Green synthesis, characterization and antimicrobial activity of silver nanoparticles using methanolic root extracts of Diospyros sylvatica. J. Environ Sci (China). 2017 May: 55:157-163. doi: 10.1016/j.jes.2016.04.027. Epub 2016 Aug 26.) Regarding claim 6: While Hoag teaches the use of metal salt; Hoag does not explicit teach the use metal acetate salt. However, Pethakamsetty teaches the use of silver acetate as the metal in producing metal nanoparticles using plant extracts. It would have been obvious to one of ordinary skill in the art before the effective filing date to have used silver acetate as the metal in the process of Hoag. One of ordinary skill in the art would have been motivated to do so to produce silver nanoparticles. One of ordinary skill in the art would have had a reasonable expectation of success for doing so because both Hoag and Pethakamsetty demonstrates the use of metal salt to produce metal nanoparticles. Claim(s) 8 is/are rejected under 35 U.S.C. 103 as being unpatentable Hoag (WO 2009140694), in view of: Korus (Korus. Effect of preliminary processing and method of preservation on the content of selected antioxidative compounds in kale (Brassica oleracea L. var. acephala) leaves. Food Chemistry. Vol. 129, Issue 1, pages 149-154, 2011.), Sankar (Sankar. Origanum vulgare mediated biosynthesis of silver nanoparticles for its antibacterial and anticancer activity. Colloids and Surfaces B: Biointerfaces, 108 (2013) 80-84.), and Erdogan (Erdogan. Green synthesis of silver nanoparticles via Cynara scolymus leaf extracts: The characterization, anticancer potential with photodynamic therapy in MCF7 cells. PLoS. 2019 Jun 20;14(6):e0216496. doi: 10.1371/journal.pone.0216496. eCollection 2019.) Regarding claim 8: Hoag does not teach artichoke plant extract. However, Erdogan teaches that artichoke extract may be used to produce metal nanoparticles. [Title] Given this; it would have been obvious for one of ordinary skill in the art before the effective filing date to include artichoke extract in the composition comprising plant extract of Hoag. One of ordinary skill in the art would have been motivated to do so to produce metal nanoparticles. One of ordinary skill in the art would have had a reasonable expectation of success for doing so because the art recognizes that artichoke can be used to make metal nanoparticles. Claim(s) 11 is/are rejected under 35 U.S.C. 103 as being unpatentable Hoag (WO 2009140694), in view of: Korus (Korus. Effect of preliminary processing and method of preservation on the content of selected antioxidative compounds in kale (Brassica oleracea L. var. acephala) leaves. Food Chemistry. Vol. 129, Issue 1, pages 149-154, 2011.), Sankar (Sankar. Origanum vulgare mediated biosynthesis of silver nanoparticles for its antibacterial and anticancer activity. Colloids and Surfaces B: Biointerfaces, 108 (2013) 80-84.), and Lu (Lu. Biochemistry, Dissolution and Solubility. [Updated 2020 Sep 15]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK431100/.) Regarding claim 11: Hoag does not teach pre-heating before combining the dissolved metal ion with the composition comprising plant extract. However, Lu teaches that solubility is the maximum concentration of a solute that can dissolve in a solvent at a given temperature. [Introduction] In the instant case, Lu establishes that dissolution is temperature dependent. Given this, it would have been obvious for one of ordinary skill in the art before the effective filing date to have heated the metal salt in solution. One of ordinary skill in the art would have been motivated to do so to adjust the solubility of the metal salt to make a metal ion solution. One of ordinary skill in the art would have had a reasonable expectation of success for doing so because the adjustment of result effective variable is routinely practiced in the art. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Emily M Le whose telephone number is (571)272-0903. The examiner can normally be reached M-F, 8 am-4:30pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /EMILY M LE/Supervisory Patent Examiner, Art Unit 1793
Read full office action

Prosecution Timeline

Show 2 earlier events
Aug 22, 2025
Response Filed
Sep 30, 2025
Final Rejection mailed — §103, §112
Feb 27, 2026
Response after Non-Final Action
Mar 27, 2026
Applicant Interview (Telephonic)
Mar 27, 2026
Request for Continued Examination
Mar 30, 2026
Response after Non-Final Action
Mar 31, 2026
Examiner Interview Summary
Aug 11, 2026
Non-Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12690710
TEMPERATURE CONTROL FOR EXTRACTED BEVERAGES, INCLUDING COFFEE, VIA CONTROLLED VACUUM, AND ASSOCIATED SYSTEMS AND METHODS
4y 0m to grant Granted Jul 28, 2026
Patent 12691425
CARBONATION CHAMBER
2y 5m to grant Granted Jul 28, 2026
Patent 12559513
AROMATIC GLYCOSIDE AND METHOD FOR PRODUCING THE GLYCOSIDE
2y 10m to grant Granted Feb 24, 2026
Patent 12527333
FOODSTUFF PRODUCTS, INGREDIENTS, PROCESSES AND USES
6y 3m to grant Granted Jan 20, 2026
Patent 12514260
EMULSIFYING SALT-FREE AND STARCH STABILIZED CHEESE
5y 5m to grant Granted Jan 06, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
18%
Grant Probability
15%
With Interview (-3.1%)
4y 6m (~10m remaining)
Median Time to Grant
High
PTA Risk
Based on 170 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month